Renal Oncocytoma Overview

Save information for later
Sign Up

Learn About Renal Oncocytoma

What is the definition of Renal Oncocytoma?
Renal oncocytoma is a benign (noncancerous) growth of the kidney. Renal oncocytoma generally do not cause any signs or symptoms and are often discovered incidentally (by chance) while a person is undergoing diagnostic imaging for other conditions. Some people with Renal oncocytoma will have abdominal or flank pain; blood in the urine; and/or an abdominal mass. Although these tumors can occur in people of all ages, they most commonly develop in men who are over age 50. The exact underlying cause of most isolated (single tumor affecting one kidney) Renal oncocytomas is unknown. Multiple and bilateral (affecting both kidneys) Renal oncocytomas sometimes occur in people with certain genetic syndromes such as tuberous sclerosis complex and Birt-Hogg-Dube syndrome.
What are the alternative names for Renal Oncocytoma?
  • Renal oncocytoma
  • Oncocytoma kidney
  • Oncocytoma renal
Who are the top Renal Oncocytoma Local Doctors?
Dr. Robert S. Kang
Otolaryngology | General Surgery | Plastic Surgery
Dr. Robert S. Kang
Otolaryngology | General Surgery | Plastic Surgery

The Regents Of The University Of California

10833 Le Conte Ave, 
Los Angeles, CA 
 (5.0 mi)
Experience:
21+ years
Languages Spoken:
English

Robert Kang is an Otolaryngologist and a General Surgeon in Los Angeles, California. Dr. Kang has been practicing medicine for over 21 years and is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Melanoma, Empyema, Angiosarcoma of the Scalp, Bone Marrow Aspiration, and Gastrostomy.

Dr. Jennifer A. Linehan
Urology
Dr. Jennifer A. Linehan
Urology

Providence Saint Johns Medical Foundation

2121 Santa Monica Blvd, 
Santa Monica, CA 
 (7.9 mi)
310-829-5511
Experience:
21+ years
Languages Spoken:
English
Offers Telehealth

Jennifer Linehan is an Urologist in Santa Monica, California. Dr. Linehan has been practicing medicine for over 21 years and is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. Her top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Bladder Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Abie A. Mendelsohn
Otolaryngology
Dr. Abie A. Mendelsohn
Otolaryngology

Geoffrey Trenkle Do A Professional Medical Corporation

1700 E Cesar E Chavez Ave, Suite 2500, 
Los Angeles, CA 
 (8.7 mi)
323-268-6731
Languages Spoken:
English
Offers Telehealth

Abie Mendelsohn is an Otolaryngologist in Los Angeles, California. Dr. Mendelsohn and is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Sialadenitis, Laryngectomy, and Thyroidectomy.

View All Doctors
What are the latest Renal Oncocytoma Clinical Trials?
Renal Cancer Detection With Liquid Biopsy
Renal Cancer Detection With Liquid Biopsy
Enrollment Status: Recruiting
Publish Date: January 30, 2024
Intervention Type: Diagnostic test

Summary: Glycosaminoglycans (GAGs) were significantly altered in localized as well advanced RCC compared to healthy samples. In addition, GAG scores correlated with progression-free survival and overall survival (OS) in a prospective cohort of patients with metastatic ccRCC and localized RCC. However, it is still unknown whether alterations in plasma and urine GAGs are exquisitely specific to RCC or are sh...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective Diagnostic Cohort Study to Compare the Accuracy of Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
A Prospective Diagnostic Cohort Study to Compare the Accuracy of Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
Enrollment Status: Recruiting
Publish Date: December 14, 2023

Summary: The goal of this clinical trial is to better tell apart whether kidney tumors are benign (not cancer) or malignant (cancer) based on a biopsy or imaging tests and ask patients how they feel about decisions they make about treatment of their kidney tumor. The main objectives are: To estimate and compare the diagnostic accuracy of renal mass biopsy alone, PEER (with renal mass biopsy), and 99mTc-ses...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center